Publication: Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma
1
Issued Date
2012-01-13
Resource Type
ISSN
16878469
16878450
16878450
Other identifier(s)
2-s2.0-84855601143
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Oncology. (2012)
Suggested Citation
Boonchu Kulapaditharom, Vipa Boonkitticharoen, Chanika Sritara Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma. Journal of Oncology. (2012). doi:10.1155/2012/687934 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/15015
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma
Other Contributor(s)
Abstract
Background. High circulating vascular endothelial growth factor (VEGF) levels tend to reflect tumor aggressiveness for being associated with tumor progression and prognosis. Measurement of soluble VEGF receptor-1 (sVEGFR-1) may improve diagnostic power of VEGF assay. Methods. This study investigated regulation of plasma VEGF by sVEGFR-1 in 82 patients with head and neck squamous cell carcinoma compared with 32 healthy subjects to obtain information for assay characterization. Results. Normality or abnormality of VEGF/sVEGFR-1secretion patterns was rated into five diagnostic levels from definitely abnormal (likelihood ratios) (LRs = 4-∞) to definitely normal (LRs = 0-0.17). Because of ineffective VEGF regulation, high grade tumor had a greater chance (62.5) than low grade tumor (20) in expressing a definitely abnormal pattern and a lower chance to express the normal pattern (P=0.007). VEGF alone had much lower diagnostic power in differentiating between normal (LRs = 0.3-0.9) and abnormal secretion patterns (LRs = 2.2-2.4). Conclusions. VEGF dysregulation is suggestive of tumor aggressiveness for causing persistent plasma VEGF elevation. sVEGFR-1 improves diagnostic power of VEGF assay particularly in identifying subset of low grade tumor with underlying aggressive disease and ruling out aggressiveness in subset of high grade tumor. Copyright © 2012 Boonchu Kulapaditharom et al.